282 related articles for article (PubMed ID: 30047092)
1. Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression.
Bhawe K; Roy D
Cell Oncol (Dordr); 2018 Oct; 41(5):465-484. PubMed ID: 30047092
[TBL] [Abstract][Full Text] [Related]
2. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.
Garneau H; Paquin MC; Carrier JC; Rivard N
J Cell Physiol; 2009 Nov; 221(2):350-8. PubMed ID: 19562678
[TBL] [Abstract][Full Text] [Related]
3. Essential roles of mitochondrial biogenesis regulator Nrf1 in retinal development and homeostasis.
Kiyama T; Chen CK; Wang SW; Pan P; Ju Z; Wang J; Takada S; Klein WH; Mao CA
Mol Neurodegener; 2018 Oct; 13(1):56. PubMed ID: 30333037
[TBL] [Abstract][Full Text] [Related]
4. A common set of gene regulatory networks links metabolism and growth inhibition.
Cam H; Balciunaite E; Blais A; Spektor A; Scarpulla RC; Young R; Kluger Y; Dynlacht BD
Mol Cell; 2004 Nov; 16(3):399-411. PubMed ID: 15525513
[TBL] [Abstract][Full Text] [Related]
5. Nuclear respiratory factor 1 promotes the growth of liver hepatocellular carcinoma cells via E2F1 transcriptional activation.
Wang D; Wan B; Zhang X; Sun P; Lu S; Liu C; Zhu L
BMC Gastroenterol; 2022 Apr; 22(1):198. PubMed ID: 35448958
[TBL] [Abstract][Full Text] [Related]
6. A role for E2F activities in determining the fate of Myc-induced lymphomagenesis.
Rempel RE; Mori S; Gasparetto M; Glozak MA; Andrechek ER; Adler SB; Laakso NM; Lagoo AS; Storms R; Smith C; Nevins JR
PLoS Genet; 2009 Sep; 5(9):e1000640. PubMed ID: 19749980
[TBL] [Abstract][Full Text] [Related]
7. Id2 leaves the chromatin of the E2F4-p130-controlled c-myc promoter during hepatocyte priming for liver regeneration.
Rodríguez JL; Sandoval J; Serviddio G; Sastre J; Morante M; Perrelli MG; Martínez-Chantar ML; Viña J; Viña JR; Mato JM; Avila MA; Franco L; López-Rodas G; Torres L
Biochem J; 2006 Sep; 398(3):431-7. PubMed ID: 16776654
[TBL] [Abstract][Full Text] [Related]
8. E2F4 regulatory program predicts patient survival prognosis in breast cancer.
Khaleel SS; Andrews EH; Ung M; DiRenzo J; Cheng C
Breast Cancer Res; 2014 Dec; 16(6):486. PubMed ID: 25440089
[TBL] [Abstract][Full Text] [Related]
9. Integrative bioinformatics analysis of transcriptional regulatory programs in breast cancer cells.
Niida A; Smith AD; Imoto S; Tsutsumi S; Aburatani H; Zhang MQ; Akiyama T
BMC Bioinformatics; 2008 Sep; 9():404. PubMed ID: 18823535
[TBL] [Abstract][Full Text] [Related]
10. Tetramethylpyrazine downregulates transcription of the CXC receptor 4 (CXCR4) via nuclear respiratory factor‑1 (Nrf‑1) in WERI‑Rb1 retinoblastoma cells.
Wu N; Yang Y; Yu N; Wu Y; Han X; Chen S; Zhang J; Chen X; Wu C; Yang M; Qiu J; Ge J; Yu K; Zhuang J
Oncol Rep; 2019 Sep; 42(3):1214-1224. PubMed ID: 31322174
[TBL] [Abstract][Full Text] [Related]
11. Pathway Analysis of ChIP-Seq-Based NRF1 Target Genes Suggests a Logical Hypothesis of their Involvement in the Pathogenesis of Neurodegenerative Diseases.
Satoh J; Kawana N; Yamamoto Y
Gene Regul Syst Bio; 2013; 7():139-52. PubMed ID: 24250222
[TBL] [Abstract][Full Text] [Related]
12. Synergism and Antagonism of Two Distinct, but Confused, Nrf1 Factors in Integral Regulation of the Nuclear-to-Mitochondrial Respiratory and Antioxidant Transcription Networks.
Zhang S; Deng Y; Xiang Y; Hu S; Qiu L; Zhang Y
Oxid Med Cell Longev; 2020; 2020():5097109. PubMed ID: 33376579
[TBL] [Abstract][Full Text] [Related]
13. Identification and analysis of the regulatory network of Myc and microRNAs from high-throughput experimental data.
Xiong L; Jiang W; Zhou R; Mao C; Guo Z
Comput Biol Med; 2013 Sep; 43(9):1252-60. PubMed ID: 23930820
[TBL] [Abstract][Full Text] [Related]
14. Effects of
Zhang GM; Deng MT; Lei ZH; Wan YJ; Nie HT; Wang ZY; Fan YX; Wang F; Zhang YL
Reproduction; 2017 Aug; 154(2):111-122. PubMed ID: 28624767
[TBL] [Abstract][Full Text] [Related]
15. p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes.
Pippa R; Espinosa L; Gundem G; García-Escudero R; Dominguez A; Orlando S; Gallastegui E; Saiz C; Besson A; Pujol MJ; López-Bigas N; Paramio JM; Bigas A; Bachs O
Oncogene; 2012 Sep; 31(38):4207-20. PubMed ID: 22179826
[TBL] [Abstract][Full Text] [Related]
16. lncRNAs and MYC: An Intricate Relationship.
Iaccarino I
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704924
[TBL] [Abstract][Full Text] [Related]
17. Nrf1 is paved as a new strategic avenue to prevent and treat cancer, neurodegenerative and other diseases.
Yuan J; Zhang S; Zhang Y
Toxicol Appl Pharmacol; 2018 Dec; 360():273-283. PubMed ID: 30267745
[TBL] [Abstract][Full Text] [Related]
18. MYC, Metabolic Synthetic Lethality, and Cancer.
Hsieh AL; Dang CV
Recent Results Cancer Res; 2016; 207():73-91. PubMed ID: 27557535
[TBL] [Abstract][Full Text] [Related]
19. The C-terminal domain of Nrf1 negatively regulates the full-length CNC-bZIP factor and its shorter isoform LCR-F1/Nrf1β; both are also inhibited by the small dominant-negative Nrf1γ/δ isoforms that down-regulate ARE-battery gene expression.
Zhang Y; Qiu L; Li S; Xiang Y; Chen J; Ren Y
PLoS One; 2014; 9(10):e109159. PubMed ID: 25290918
[TBL] [Abstract][Full Text] [Related]
20. Wide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysis.
Lee BK; Bhinge AA; Iyer VR
Nucleic Acids Res; 2011 May; 39(9):3558-73. PubMed ID: 21247883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
